Treatment of primary parotid non-Hodgkin' s lymphoma: an analysis of 29 patients
- VernacularTitle:29例原发腮腺非霍奇金淋巴瘤的治疗结果分析
- Author:
Wendong GU
;
Yan FENG
- Publication Type:Journal Article
- Keywords:
Lymphoma, parotid/radiotherapy;
Lymphoma, parotid/chemotherapy;
Combined modality therapy;
Prognosis
- From:
Chinese Journal of Radiation Oncology
1993;0(03):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the clinical characteristics, treatment and prognosis of primary parotid non-Hodgkin's lymphoma. Methods From March 1988 to February 2001, twenty-nine patients with primary parotid non-Hodgkin' s lymphoma treated in our hospital were retrospectively analyzed. The data were analyzed according to the following factors: sex, age, stage, pathologic classification, chemotherapy given or not, cycles of chemotherapy, radiotherapy given or not, and the dose at the parotid. Kaplan-Meier method and Log-rank method were used in the statistic analysis. Results The overall 5-year and 10-year survival rates were 73. 3% and 51.0% . Stage and pathologic classification were prognostic factors in our statistic analysis. The 5-year survival rates were 81.6% and 25.0% for early stage ( I E + IIE) and advanced stage ( III E + IVE) patients, with the difference significant ( P
